CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
PHI Group, Incorporation Company Snapshot
PHI Group, Incorporation operates in the Management services sector. In addition to historical fundamental analyses, the complete report available to purchase compares PHI Group, Incorporation with three other miscellaneous service companies in North America: Revance Therapeutics Inc (2016 sales of $300,000.00 of which 100% was Botulinum Toxin Products), Intra-Cellular Therapies Inc ($330,702.00 of which 100% was Pharmaceutical), and Dicerna Pharmaceuticals Inc ($295,000.00 of which 100% was RNA Interference (RNAi) Therapeutics).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
PHI Group, Incorporation
  Stock Performance Chart for PHI Group, Incorporation
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): .03
(Figures in U.S. Dollars)
1 Week 62.3%   13 Weeks -17.2%  
4 Weeks -59.4%   52 Weeks -97.2%  
 
PHI Group, Incorporation Key Data:
  Ticker: PHIL Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Management Services
  2016 Sales 332,050
(Year Ending Jan 2017).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 436,987
  Fiscal Yr Ends: June Shares Outstanding: 15,838,595
  Share Type: Common Closely Held Shares: 7,736,493
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.